OpenPay is due for a major re-rate.
It has such a small market cap relative to its peers .
Good luck to all patient holders .
The company will release quarterly results soon and again in 3 months. The quarter on quarter positive growth rates should fuel this undervalued stock .
The patient will be rewarded for holding . If I had cash I would buy at these cheap prices.